Pregnancy labeling changes

FDA plans to revise its regulatory requirements for the pregnancy section of pharmaceutical labeling. An advanced notice of proposed rulemaking will put forth "preliminary proposals for changing the current requirements and will invite comments on all aspects of the notice." This is a long-term action and FDA gave no timetable.